- Expansion of business area with Molecular diagnosis

- Expansion of the 2^nd factory in Suwon (MDT Production Plant)
- Listed on EU Common list of COVID-19 antigen tests
  agreed by EU Health Security Committee
- Establish US entity

- Expansion of the 1^st factory in Suwon
  (RDT Production Plant / Monthly Capacity : 100 Mil tests)
- Acquired COVID-19 Ag Home Test Kit approval from Korea MFDS (1st and official)
- COVID-19 Ag for professional and home use is formally registered globally.
- Awarded with $100 million Export Tower in 2021 (Export reached $100 million in 2020)
- Acquired COVID-19 Ag Home Test Saliva Export Certification
- Global presence of over 50 countries around the world

- ISO 13485 : 2016 Certification
- Applied WHO PQ for 3 ERPD approved Malaria RDT
- Acquired KFDA/CE for 3 COVID-19 RDTs

- Acquired certification for 3 types of Malaria (GF ERPD)

- ISO 13485:2012 Certification

- KGMP Certification (by KFDA)

- Launched 20 types of IVD products for Human

- ISO 13485 Certification 

- Launched BIOCREDIT Influenza A&B Antigen

- Launched 10 Veterinary IVD products

- ISO 9001 Certification

- Development of Black Gold Particle Technology

- Established Rapigen R&D Center

- Establishment of Rapigen Co.,LTD